for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

NanJing Medical Company Limited

600713.SS

Latest Trade

4.31CNY

Change

0.04(+0.94%)

Volume

3,031,408

Today's Range

4.28

 - 

4.32

52 Week Range

3.94

 - 

5.53

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4.27
Open
4.29
Volume
3,031,408
3M AVG Volume
64.56
Today's High
4.32
Today's Low
4.28
52 Week High
5.53
52 Week Low
3.94
Shares Out (MIL)
1,041.61
Market Cap (MIL)
4,447.68
Forward P/E
--
Dividend (Yield %)
2.34

Latest Developments

More

Nanjing Pharmaceutical Plans To Buy At Least 51% Stake Of Pharma Firm

Nanjing Pharmaceutical Says Board Elects Zhou Jianjun As Chairman

Nanjing Pharmaceutical Says Chairman Tao Yun Retires

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About NanJing Medical Company Limited

NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.

Industry

Biotechnology & Drugs

Contact Info

Building 8

(Nanjng Intrntnl Hlth Indl Prk,No.1 Yj

Xiaoxingli, Yuhuatai District

+86.25.84552601

http://english.njyy.com

Executive Leadership

Jianjun Zhou

Chairman of the Board

Yijie Shu

President

Jian Sun

Finance Director, Chief Accounting Officer

Qiushuang Wang

Vice President

Ningju Xu

Vice President, Chief Audit Officer

Key Stats

Price To Earnings (TTM)
12.08
Price To Sales (TTM)
0.12
Price To Book (MRQ)
1.14
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
209.07
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
11.02
Return on Equity (TTM)
2.11

Latest News

Latest News

BRIEF-Nanjing Pharmaceutical signs letter of intent on medical welfare management project

* Says it signed letter of intent with Wanhu Health, a PBM company, to cooperate on medical welfare management project related business through technology JV and Welfare Management Center for patients with chronic diseases

BRIEF-Nanjing Pharmaceutical issues 2017 1st tranche super short-term financing notes worth 2 bln yuan

* Says it issued 2017 1st tranche super short-term financing notes worth 2 billion yuan with a term of 90 days and interest rate of 4.5 percent

BRIEF-Nanjing Pharmaceutical to sell 9 pct stake in China Healthcare Supply Chain Service for 12.5 mln yuan

* Says it plans to sell 9 percent stake in China Healthcare Supply Chain Service Co Ltd for 12.5 million yuan

BRIEF-Nanjing Pharmaceutical to acquire shares in three medicine related firms

* Says it plans to acquire 20 percent stake in Jiang Su Hua Xiao Pharmal Euhcal Lugisinls Co Ltd

BRIEF-Nanjing Pharmaceutical to pay A shares annual div for FY 2016 on June 21

* Says it will pay cash dividend of 0.045 yuan(before tax)/share for 2016 to shareholders of record on June 20

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up